miR-451a was selectively sorted into exosomes and promoted the progression of esophageal squamous cell carcinoma through CAB39

Hsu PK, Chen HS, Wang BY, Wu SC, Liu CY, Shih CH, et al. Hospital type- and volume-outcome relationships in esophageal cancer patients receiving non-surgical treatments. World J Gastroenterol. 2015;21:1234–42.

Article  PubMed  PubMed Central  Google Scholar 

Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in china, 2015. CA: a cancer J Clin. 2016;66:115–32.

Google Scholar 

Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet (Lond, Engl). 2013;381:400–12.

Article  Google Scholar 

Tlsty TD, Coussens LM. Tumor stroma and regulation of cancer development. Annu Rev Pathol. 2006;1:119–50.

Article  CAS  PubMed  Google Scholar 

Paskeh MDA, Entezari M, Mirzaei S, Zabolian A, Saleki H, Naghdi MJ, et al. Emerging role of exosomes in cancer progression and tumor microenvironment remodeling. J Hematol Oncol. 2022;15:83.

Article  PubMed  Google Scholar 

Chen BY, Sung CW, Chen C, Cheng CM, Lin DP, Huang CT, et al. Advances in exosomes technology. Clin Chim acta; Int J Clin Chem. 2019;493:14–9.

Article  CAS  Google Scholar 

Sreekumar R, Sayan BS, Mirnezami AH, Sayan AE. Microrna control of invasion and metastasis pathways. Front Genet. 2011;2:58.

Article  PubMed  PubMed Central  Google Scholar 

Ahmed FE. Role of mirna in carcinogenesis and biomarker selection: A methodological view. Expert Rev Mol Diagnos. 2007;7:569–603.

Article  CAS  Google Scholar 

Yamashita T, Takahashi Y, Takakura Y. Possibility of exosome-based therapeutics and challenges in production of exosomes eligible for therapeutic application. Biol Pharm Bull. 2018;41:835–42.

Article  CAS  PubMed  Google Scholar 

Saliminejad K, Khorram Khorshid HR, Soleymani Fard S, Ghaffari SH. An overview of micrornas: Biology, functions, therapeutics, and analysis methods. J Cell Physiol. 2019;234:5451–65.

Article  CAS  PubMed  Google Scholar 

Yamada Y, Arai T, Sugawara S, Okato A, Kato M, Kojima S, et al. Impact of novel oncogenic pathways regulated by antitumor mir-451a in renal cell carcinoma. Cancer Sci. 2018;109:1239–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shen YY, Cui JY, Yuan J, Wang X. Mir-451a suppressed cell migration and invasion in non-small cell lung cancer through targeting atf2. Eur Rev Med Pharmacol Sci. 2018;22:5554–61.

PubMed  Google Scholar 

Riquelme I, Tapia O, Leal P, Sandoval A, Varga MG, Letelier P, et al. Mir-101-2, mir-125b-2 and mir-451a act as potential tumor suppressors in gastric cancer through regulation of the pi3k/akt/mtor pathway. Cell Oncol (Dordr). 2016;39:23–33.

Article  CAS  PubMed  Google Scholar 

Teng Y, Ren Y, Hu X, Mu J, Samykutty A, Zhuang X, et al. Mvp-mediated exosomal sorting of mir-193a promotes colon cancer progression. Nat Commun. 2017;8:14448.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang L, Yu D. Exosomes in cancer development, metastasis, and immunity. Biochim et Biophys acta Rev cancer. 2019;1871:455–68.

Article  CAS  Google Scholar 

Hornick NI, Huan J, Doron B, Goloviznina NA, Lapidus J, Chang BH, et al. Serum exosome microrna as a minimally-invasive early biomarker of aml. Sci Rep. 2015;5:11295.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen J, Yao D, Chen W, Li Z, Guo Y, Zhu F, et al. Serum exosomal mir-451a acts as a candidate marker for pancreatic cancer. Int J Biol markers. 2022;37:74–80.

Article  CAS  PubMed  Google Scholar 

Jiang Y, Chen F, Ren X, Yang Y, Luo J, Yuan J, et al. Rna-binding protein col14a1, tns1, nusap1 and ywhae are valid biomarkers to predict peritoneal metastasis in gastric cancer. Front Oncol. 2022;12:830688.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang YF, Lee YC, Wang YY, Wang CH, Hou MF, Yuan SF. Ywhae promotes proliferation, metastasis, and chemoresistance in breast cancer cells. Kaohsiung J Med Sci. 2019;35:408–16.

Article  PubMed  Google Scholar 

Peng L, Yan H, Qi S, Deng L. Cab39 promotes the proliferation of nasopharyngeal carcinoma cne-1 cells via up-regulating p-jnk. Cancer Manag Res. 2020;12:11203–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rosenberger CM, Podyminogin RL, Navarro G, Zhao GW, Askovich PS, Weiss MJ, et al. Mir-451 regulates dendritic cell cytokine responses to influenza infection. J Immunol (Baltim, Md : 1950). 2012;189:5965–75.

Article  CAS  Google Scholar 

Li R, Li D, Wang H, Chen K, Wang S, Xu J, et al. Exosomes from adipose-derived stem cells regulate m1/m2 macrophage phenotypic polarization to promote bone healing via mir-451a/mif. Stem cell Res Ther. 2022;13:149.

Article  PubMed  PubMed Central  Google Scholar 

Liu Z, Zhao Y, Kong P, Liu Y, Huang J, Xu E, et al. Integrated multi-omics profiling yields a clinically relevant molecular classification for esophageal squamous cell carcinoma. Cancer cell. 2023;41:181–95.e189.

Article  CAS  PubMed  Google Scholar 

Flavell RA, Sanjabi S, Wrzesinski SH, Licona-Limón P. The polarization of immune cells in the tumour environment by tgfbeta. Nat Rev Immunol. 2010;10:554–67.

Article  CAS  PubMed  Google Scholar 

Picone P, Sabatino MA, Ditta LA, Amato A, San Biagio PL, Mulè F, et al. Nose-to-brain delivery of insulin enhanced by a nanogel carrier. J Control Release. 2018;270:23–36.

Article  CAS  PubMed  Google Scholar 

Batlle E, Massagué J. Transforming growth factor-β signaling in immunity and cancer. Immunity. 2019;50:924–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tauriello DVF, Sancho E, Batlle E. Overcoming tgfβ-mediated immune evasion in cancer. Nat Rev Cancer. 2022;22:25–44.

Article  CAS  PubMed  Google Scholar 

Bhome R, Del Vecchio F, Lee GH, Bullock MD, Primrose JN, Sayan AE, et al. Exosomal micrornas (exomirs): Small molecules with a big role in cancer. Cancer Lett. 2018;420:228–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang Y, Sang ZY, Ma J, Zhu YP, Wu SF. Kras. ywhae, sp1 and msra as biomarkers in endometrial cancer. Transl cancer Res. 2021;10:1295–312.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao J, Ma X, Xu H. Mir-29b-3p inhibits 22rv1 prostate cancer cell proliferation through the ywhae/bcl-2 regulatory axis. Oncol Lett. 2022;24:289.

Article  CAS  PubMed  PubMed Central  Google Scholar 

留言 (0)

沒有登入
gif